What we need tofightclimate change is woolly mammoths said no climate scientist, ever.
But thats not deterring a hotshot bioscience start-up from peddling its genetic tinkering as a way to reduce greenhouse gas emissions. On its slick website, newly-formed Colossal Laboratories prominently states that its top core goal is to decelerate melting of the arctic permafrost. Melting permafrost releases immense quantities of methane into the atmosphere, which contributes to global warming.
To achieve their stated goal, the founders plan to genetically engineer a hybrid of the Asian elephant and the extinct woolly mammoth, which lastlived about 4,000 years ago. If you dont immediately see how that relates to the climate crisis, hang on.
The pitch goes like this. First, the gene-splicing wizards will synthesize some carefully chosen woolly mammoth genes the animal'scomplete genetic sequence has been known since 2015 and implant them in an egg cell from an Asian elephant. Egg harvesting is hugely complex with elephants, and the Asian elephant is endangered. (Colossals fallback strategy is to make an embryo from stem cells.)
'What we need to fightclimate change is woolly mammoths' said no climate scientist, ever.
Next, theyll fertilize the egg and implant the modified embryo in an artificial womb. Actually, theres one step before that: inventing an artificial womb that can gestate a200-poundfetus for almost two years. Some preliminary experimental work with mice has been conducted, but that research utilized an embryo taken from a healthy mother mouse.
Once the baby mammoth-elephant emerges from the artificial womb, theyll need to raise it to maturity. That assumes that they figure out how to recreate the nurturing environment of an intensely social and highly intelligent species. And theyll need a lot of these babies to create a viable herd. Were finally getting to the climate part.
The next step is to relocate the herd to Siberia because thats where the permafrost is. According to Sergey Zimov, a Russian geophysicist who also does work in paleoecology, the introduction of the mammoth-elephants into the wet mossy tundra should induce the emergence of dry grasslands as they existed in the Late Pleistocene, roughly 10,00015,000 years ago.
This transformation of the arctic ecosystem, says Zimov, has multiple climate benefits. Grasslands will sequester more carbon in their root systems, and theyll reflect more sunlight, which reduces atmospheric heating.
And the big win is that when the mighty herds of mammoth-elephants trample insulating layers of snow, it will allow the frigid arctic air to chill the permafrost and thereby retain the ancient methane held within. Goal achieved.
Their disingenuous posturing debases the public discourse around climate change, which remains the planets most pressing issue.
But it doesnt pencil out. Suppose, optimistically, Colossal raises 100 healthy adult mammoth-elephants by 2040, and they double in population every 20 years. By 2200, they would have about 25,000 animals. Assuming you need a density of one beast per 10 square kilometers to have any ecological impact, those 25,000 would inhabit about one percent of Earths 22.8 million square kilometers of vulnerable permafrost.
So even if Colossal overcame the numerous formidable technological hurdles of creating hybrids of endangered elephants and an extinct relative, andthe company wasable to establish self-sustaining herds, and Zimovs fuzzy speculations about the effect of large herbivores on the tundra proved correct, the impact would be negligible even in 2200, a century after the climate crisis will likely be resolved, one way or the other.
The smart people at Colossal know this, so why are they selling us their bioscience venture as a climate change solution?
To answer that question, its helpful to look at the people involved. Lead scientist George Church of Harvard has been a disruptive rockstar in the genetics world for three decades. The business guy is whiz-kid serial entrepreneur Ben Lamm, who has already built a portfolio of successful high-tech start-ups.
And then there are the money guys.
Among the investors are the Winkelvoss twins, who made billions in Bitcoin after successfully suing Mark Zuckerberg for stealing the idea for Facebook. When asked how Colossal would make money, Cameron Winkelvoss suggested, there could be a lot of economic opportunity over time, which might include television or even parks for extinct animals, like"Jurassic Park.
The lead investor is billionaire movie producer Thomas Tull, founder of Legendary Entertainment, the company that co-produced the movie Jurassic World.
The prevalence of media executives and high-tech finance types in the Colossal boardroom makes you wonder if the companys ostensible environmental goals are secondary to a different agenda. There are zero climate scientists on their scientific advisory board. It seems likely that the true purpose of the ecosystems-cum-permafrost narrative is to leverage the virtuous cachet of fighting climate change and deflect ethical concerns around engineering transgenic species.
The financial backers will deem the company a success if it spins out some valuable genetic engineering tools or opens up new areas in the bioscience market, such as the artificial womb.
The woolly mammoth, the permafrost and the saving-the-planet facade are for creating headlines and media buzz, which wouldnt be so objectionable if climate change werent such a grave and urgent threat to the planets biosphere.
You can embrace the brilliant work Colossal is doing in genetics while rejecting the crass promotion of de-extinction as a meaningful climate measure. Their disingenuous posturing debases the public discourse around climate change, which remains the planets most pressing issue.
The crisis is escalating. Using climate advocacy as a phony marketing tool is a distraction we can ill afford.
Follow Cognoscenti on Facebook and Twitter.
Continue reading here:
Dont Count On Woolly Mammoths To Save The Planet - WBUR
- Secret to eternal youth? John Cleese extols virtues of stem cell treatment - The Guardian - April 26th, 2024
- Cabinet approves two bills on regenerative medicine - - April 26th, 2024
- Parental Fury After Stem Cell Bank Ruins Thousands of Samples in Singapore - Bloomberg - April 24th, 2024
- Pressure in the womb may influence facial development - Phys.org - April 24th, 2024
- Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis - Nature.com - April 24th, 2024
- Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform - FiercePharma - April 19th, 2024
- The Stem Cells Market expected to grow at the value of USD 28.1 Billion by 2030 with a 10.48% CAGR. - WhaTech - April 19th, 2024
- Scientists produce in vitro model of cell differentiation during early facial development - Phys.org - April 19th, 2024
- Somite: AI-Based Stem Cell Therapy Company Closes $5.3 Million In Funding - Pulse 2.0 - April 19th, 2024
- Paralyzed man who can walk again shows potential benefit of stem cell therapy - ABC News - April 5th, 2024
- Stem Cells Market Innovations Investigated by Industry Overview and Global Forecast - WhaTech - April 5th, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - University of Wisconsin-Madison - April 1st, 2024
- The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation - Nature.com - April 1st, 2024
- Signatures of Autofluorescence Used To Study Stem Cells Aging in the Brain - Technology Networks - March 30th, 2024
- Two decades of embryonic stem cells: a historical overview - March 28th, 2024
- Researchers at Phoenix Children's First in the World to Produce Mouse Lungs in Rats - The Malaysian Reserve - March 26th, 2024
- Unlocking the mysteries of early human development through blastoid models - News-Medical.Net - March 24th, 2024
- Unlocking the Secrets of Aging: Researchers Reveal Key to Intestinal Balance - SciTechDaily - March 17th, 2024
- Human stem-cell-based therapy for Parkinson's disease proven safe PET - BioNews - March 13th, 2024
- Exploring the inner workings of stem cells: When location changes the message - Phys.org - March 9th, 2024
- Confronting IVF: Human Embryos Are Persons With a Right to Life - Walter Bradley Center for Natural and Artificial Intelligence - March 7th, 2024
- When Location Changes the Message - UConn Today - University of Connecticut - March 7th, 2024
- Distinct pathways drive anterior hypoblast specification in the implanting human embryo - Nature.com - March 6th, 2024
- In light of the Alabama court ruling, a look at the science of IVF : Short Wave - NPR - March 3rd, 2024
- The weird way Alabamas embryo ruling takes on artificial wombs - MIT Technology Review - February 25th, 2024
- Alabama's biggest hospital to suspend transfer of embryos after court ruling - ABC News - February 24th, 2024
- Stem Cells: FAQs Answered for Patients and Caregivers - Corporate Wellness Magazine - February 22nd, 2024
- Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells - Business Wire - February 22nd, 2024
- Breakthrough Stem Cell Treatments for Stroke Recovery: What You Need to Know - Medical Tourism Magazine - February 20th, 2024
- Global Cell Isolation Market Size To Worth USD 13.4 Billion By 2033 | CAGR of 12.5% - Yahoo Finance - February 20th, 2024
- The Mechanism of Positional Cues in Embryonic Development and Signaling Molecules in Cell Fate - Medriva - February 18th, 2024
- Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review - Cureus - February 5th, 2024
- CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from ... - Nature.com - January 29th, 2024
- Global Human Embryonic Stem Cell Market Analysis 2024-2034: A Deep Dive into Applications, End-users, and ... - GlobeNewswire - January 26th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - Yahoo News - January 14th, 2024
- Clinical applications of stem cell-derived exosomes | Signal Transduction and Targeted Therapy - Nature.com - January 12th, 2024
- How Stem Cell Embryo Models Won Method of the Year - Technology Networks - January 12th, 2024
- Changing the public perception of human embryology - ESHRE - January 11th, 2024
- How the Human Body Regenerates New Cells Every Year - Laughing Squid - January 4th, 2024
- Lab-grown models of embryos increasingly resemble the real thing | Mint - Mint - January 4th, 2024
- Singapore should ban reproductive applications of synthetic human embryos - BioEdge - January 4th, 2024
- Machine learning-based estimation of spatial gene expression pattern during ESC-derived retinal organoid ... - Nature.com - December 21st, 2023
- The development of embryos may be less shaped by genes than we thought - New Scientist - December 21st, 2023
- Embryonic stem cell - Wikipedia - December 13th, 2023
- Researchers discover a mechanism that controls the identity of stem cells - Phys.org - December 9th, 2023
- 'Fascinating and completely unexpected': Tiny robots fix neurons - FierceBiotech - December 5th, 2023
- Establishment and characterization of matched immortalized human ... - Nature.com - December 5th, 2023
- Proteomic insights into the associations between obesity, lifestyle ... - BMC Medicine - December 5th, 2023
- New therapy can treat rare and hereditary diseases - ScienceNorway - December 5th, 2023
- Scientists Still Can't Be Trusted on Gene Editing - Progressive.org - December 5th, 2023
- Harvard Apparatus Regenerative Technology and Renowned ... - Yahoo Finance - December 5th, 2023
- 4.4 Million Funding Injection Fuels World-Class Bioscience Research Programme - India Education Diary - December 3rd, 2023
- A two-kinesin mechanism controls neurogenesis in the developing ... - Nature.com - December 3rd, 2023
- What happens when nature and cities collide - CNN - December 3rd, 2023
- Pro-Life This Week: December 1, 2023 | ALL - All.org - December 3rd, 2023
- A look at the international race to create human eggs and sperm in ... - NPR - December 1st, 2023
- Synthetic genetic circuits to uncover the OCT4 trajectories of ... - Science - December 1st, 2023
- Why the Novo Nordisk Foundation is betting big on stem cells - pharmaphorum - November 29th, 2023
- Charity Watchlist Helps Donors Ensure Their Year-End Gifts Don't ... - All.org - November 29th, 2023
- A green glowing monkey has been created in China. What were the ... - Genetic Literacy Project - November 29th, 2023
- Fetal Bovine Serum Market to reach USD 1.26 Bn by 2029, emerging at a CAGR of 5.3 percent according to a ne... - WhaTech Technology and Markets News - November 29th, 2023
- Implications of Gene Therapy in Dentistry and Periodontics: A ... - Cureus - November 27th, 2023
- Study shows how to treat hereditary, rare diseases - ETHealthWorld - November 27th, 2023
- Drugs identified that may reverse brain fog caused by COVID-19 - New Atlas - November 27th, 2023
- The genes that made us truly human may also make us ill - BBC.com - November 25th, 2023
- Therapy to treat rare, hereditary diseases: Study - Hindustan Times - November 25th, 2023
- How the growth of a giant single cell is intertwined with daily self-rhythms - Phys.org - November 25th, 2023
- On this day: Mahmoud Abbas becomes leader of Fatah in 2004 - In-Cyprus - November 25th, 2023
- Evaluation of A-ring hydroxymethylene-amino- triterpenoids as ... - Nature.com - November 25th, 2023
- Disruption of the autism gene and chromatin regulator KDM5A alters ... - Science - November 23rd, 2023
- Scientists Created a Monkey With Two Different Sets of DNA - Smithsonian Magazine - November 23rd, 2023
- Genomic tug of war could boost cancer therapy - Science Daily - November 23rd, 2023
- What are stem cells? Throw light on various types of stem cells and ... - Insights IAS - November 23rd, 2023
- The Paul G. Allen Family Foundation awards $10.5 million to new ... - EurekAlert - November 23rd, 2023
- Daily briefing: Why these PhD scientists went into teaching - Nature.com - November 23rd, 2023
- Innovative Therapy Targets Rare, Hereditary Diseases - Mirage News - November 23rd, 2023
- Scientists uncover "genomic tug of war" that influences ... - News-Medical.Net - November 21st, 2023
- DOT1L is a barrier to histone acetylation during reprogramming to ... - Science - November 21st, 2023
- Tumor microenvironment composition & related therapy in HCC | JHC - Dove Medical Press - November 21st, 2023
- T-Therapeutics raises $59M in series A for T-cell receptors - BioWorld Online - November 19th, 2023
Recent Comments